Alzheimer’s disease patients in the earliest stages of their disease benefited the most benefit from Eli Lilly drug donanemab, which is expected to receive an FDA decision by the end of 2023. Full results from the drug’s pivotal study were presented during the during the Alzheimer’s Association International Conference.
Kaiser Permanente is deploying Innovaccer’s healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and…
In this episode we discuss abortion and the Arizona’s House and Senate voted to repeal the 1864 law that nearly banned all abortions after this…
In this episode we discuss abortion and the Arizona’s House and Senate voted to repeal the 1864 law that nearly banned all abortions after this…
Some specific topics that should be prioritized at all levels
A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded…
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big…
Where we’ve been, where we’re going, and how healthcare organizations can protect themselves from privacy risks caused by the Meta pixel and other third-party trackers
Strategies for building the datasets needed for ACOs to take advantage of artificial intelligence, manage costs and improve outcomes for all
Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same…
